Jamie Bendrick‐Peart
Papers
1
Total Citations
49
H-Index
1
About
Jamie Bendrick-Peart is a leading figure in bioanalytical chemistry, with a primary focus on the precise quantification of immunosuppressive drugs and their metabolites. Her most impactful work centers on the development of a high-throughput U-HPLC–MS/MS assay for mycophenolic acid (MPA) and its major metabolites, including the pharmacologically active mycophenolic acid glucuronide and the potentially toxic acyl-glucuronide. This seminal 2011 paper, cited 49 times, provided a robust, rapid method for simultaneously measuring these compounds in both human plasma and urine—a critical tool for therapeutic drug monitoring in transplant patients. By enabling more accurate pharmacokinetic profiling, Bendrick-Peart’s methodology has directly supported safer, more personalized dosing regimens, helping to minimize adverse effects while maximizing immunosuppressive efficacy. Her work exemplifies the vital intersection of analytical rigor and clinical application, offering researchers and clinicians a reliable foundation for studying MPA metabolism and optimizing patient outcomes in solid organ transplantation.
Research Focus
Key Achievements
Top Papers
- 1